Literature DB >> 17848155

Empirical antibiotic therapy of sepsis in surgical intensive care unit.

Ljiljana Mihaljević1, Slobodan Mihaljević, Ivan Vasilj, Semra Cavaljuga, Fadila Serdarević, Ivan Soldo.   

Abstract

Retrospective study was conducted in surgical intensive care unit (ICU) in Clinical Hospital Center Zagreb in 2005. The aim of study was to create guidelines for empirical antibiotic therapy of sepsis in ICU for unknown causative agent based on antimicrobial susceptibility of causative bacteria. Thirty-two patients with severe sepsis were included in study and from medical records their clinical and microbiological data were analyzed. Antimicrobial susceptibility of the strains isolated from the blood-culture was tested by disk diffusion method according to CLSI (Clinical Laboratory Standard Institution). We used APACHE II score to predict the severity of illness. Mann-Whitney test and chi2 test were used to test statistical significance difference between results. Acinetobacter baumannii and Pseudomonas aeruginosa were the predominant causative agent. Acinetobacter baumannii was displaying excellent susceptibility to ampicillin+sulbactam and carbapenems, whereas Pseudomonas aeruginosa was showed good susceptibility on ceftazidim and carbapenems. Methicillin-resistant Staphylococcus aureus (MRSA), third predominant causative agent exhibiting good susceptibility to vancomycin and linezolide. The recommended therapy is empirical antibiotic therapy and should cover all important pathogens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17848155      PMCID: PMC5736121          DOI: 10.17305/bjbms.2007.3057

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  18 in total

1.  Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis.

Authors:  James C Hurley
Journal:  Med J Aust       Date:  2002-02-18       Impact factor: 7.738

Review 2.  The use of severity scores in the intensive care unit.

Authors:  Jean-Roger Le Gall
Journal:  Intensive Care Med       Date:  2005-10-22       Impact factor: 17.440

3.  Mortality risk factors of Acinetobacter baumannii bacteraemia.

Authors:  J Y Choi; Y S Park; C O Kim; Y S Park; H J Yoon; S Y Shin; Y-A Kim; Y G Song; D Yong; K Lee; J M Kim
Journal:  Intern Med J       Date:  2005-10       Impact factor: 2.048

Review 4.  Source control in the management of sepsis.

Authors:  M F Jimenez; J C Marshall
Journal:  Intensive Care Med       Date:  2001       Impact factor: 17.440

5.  Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment.

Authors:  Scott T Micek; Ann E Lloyd; David J Ritchie; Richard M Reichley; Victoria J Fraser; Marin H Kollef
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

6.  Staphylococcus aureus bacteraemia: incidence, risk factors and predictors for death in a Brazilian teaching hospital.

Authors:  A O Guilarde; M D Turchi; C M T Martelli; M G B Primo
Journal:  J Hosp Infect       Date:  2006-05-19       Impact factor: 3.926

7.  Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome.

Authors:  Marc Leone; Aurélie Bourgoin; Sylvie Cambon; Myriam Dubuc; Jacques Albanèse; Claude Martin
Journal:  Crit Care Med       Date:  2003-02       Impact factor: 7.598

8.  Long-term mortality and medical care charges in patients with severe sepsis.

Authors:  Derek Weycker; Kasem S Akhras; John Edelsberg; Derek C Angus; Gerry Oster
Journal:  Crit Care Med       Date:  2003-09       Impact factor: 7.598

9.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Authors:  R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; M M Levy
Journal:  Intensive Care Med       Date:  2004-03-03       Impact factor: 17.440

10.  EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units.

Authors:  C Brun-Buisson; P Meshaka; P Pinton; B Vallet
Journal:  Intensive Care Med       Date:  2004-03-02       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.